---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-011183"
form_type: "8-K"
ticker: "CDT"
cik: "0001896212"
company_name: "CDT Equity Inc."
filed_at: "2025-05-16T23:59:59+00:00"
generated_at: "2026-05-21T03:42:48.406632+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Conduit Pharmaceuticals announces 1-for-15 reverse stock split effective May 19, 2025

## Summary
- 1-for-15 reverse split effective May 19, 2025 at 5:00 p.m. ET; split-adjusted trading begins May 20 under ticker CDT.
- Post-split outstanding shares reduced to approximately 755,900 from roughly 11.3 million pre-split.
- No fractional shares issued; cash payment in lieu at closing price on May 19.
- Par value unchanged at $0.0001; new CUSIP number 20678X 304; warrants and equity awards proportionally adjusted.
- Stockholders approved reverse split at special meeting on May 5, 2025; board set exact ratio.

## SEC filing metadata
- accession: 0001641172-25-011183
- form_type: 8-K
- ticker: CDT
- cik: 0001896212
- company_name: CDT Equity Inc.
- filed_at: 2025-05-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.03, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1896212/000164117225011183/0001641172-25-011183-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1896212/000164117225011183/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-011183
- JSON: https://secwatch.observer/filing/0001641172-25-011183.json
- Plain text: https://secwatch.observer/filing/0001641172-25-011183.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.